LUNG vs BVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

LUNG

32.6
AI Score
VS
BVS Wins

BVS

64.3
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
EXTENDED

BVS

64score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric LUNG BVS Winner
Forward P/E 28.3286 11.976 BVS
PEG Ratio 0 1.1977 Tie
Revenue Growth 6.2% 2.7% LUNG
Earnings Growth 0.0% 69.7% BVS
Tradestie Score 32.6/100 64.3/100 BVS
Profit Margin -47.9% 9.8% BVS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED STRONG BUY BVS

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% BVS 1M: -17.4% · 3M: -19.7%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

BVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 36

RSI (14): 36.0 · Price: $11.18

Fundamentals Snapshot

Metric LUNG BVS
Market Cap — —
Forward P/E -3.1 12.6
Trailing P/E — 13.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.7%
Operating Margin -0.3% 0.1%
EPS -1.01 0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.